The Impact of Lung Recruitment Maneuver in 24-32 Weekers, and the Incidence of Bronchopulmonary Dysplasia
- Disease/Condition
- Bronchopulmonary Dysplasia
- Drug/Device/Intervention
- lung recruitment maneuver (LRM) with DrageerVN500
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Dr. R. Adhi Teguh Perma Iskandar, Sp.A(K)
- Funder
- Dr Cipto Mangunkusumo General Hospital
- Phase
- N/A
- Start date
- Oct 31, 2020
- End date
- Dec 30, 2022
- Enrollment
- 110 participants
Knowing the relationship between lung recruitment maneuver in 24-32 weeks preterm babies with the incidence of Bronchopulmonary dysplasia
hypothesis :
 
 1. The incident of dysplasia bronchopulmonary and/or death in 24-32 weekers babies on
 assist-control volume guarantee ventilation are lower in lung recruitment maneuver (LRM)
 group compare to control.
 
 2. The serum levels of surfactant protein-D in 24-32 weekers babies on assist-control
 volume guarantee ventilation are lower in lung recruitment maneuver (LRM) group compare
 to control.
 
 3. The serum concentration of CD-31+ and CD-42b- in 24-32 weekers babies on assist-control
 volume guarantee ventilation are lower in lung recruitment maneuver (LRM) group compare
 to control.
 
 4. The right and left cardiac output in 24-32 weekers babies on assist-control volume
 guarantee mode are more higher in lung recruitment maneuver (LRM) group, than group that
 did not get LRM
 
 5. The incident Patent Ductus Arteriosus in 24-32 weekers babies on assist-control volume
 guarantee ventilation are lower in lung recruitment maneuver (LRM) group compare to
 control.
 
 6. The difference tc-pCO2 - PaCO2 , tcO2 index , and strong ion difference (SID) in 24-32
 weekers babies on assist-control volume guarantee ventilation are lower in lung
 recruitment maneuver (LRM) group compare to control.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04555889
- Type
- Device Trial
Access comprehensive clinical trial information for NCT04555889 through Pure Global AI's free database. This phase not specified trial is sponsored by Dr. R. Adhi Teguh Perma Iskandar, Sp.A(K) and is currently Not yet recruiting. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 110 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.